Evolent Health, Inc.
Symbool: EVH
NYSE
31.93
USDMarktprijs vandaag
-27.2314
Koers/Winst Verhouding
0.0238
Koers/Winst Groei Verhouding
3.69B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Evolent Health, Inc. (EVH) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 677.41 | 192.8 | 188.2 | 266.3 | ||||||||||||
balance-sheet.row.short-term-investments | 118.9 | 13.8 | 14.5 | 75.7 | ||||||||||||
balance-sheet.row.net-receivables | 1480.17 | 446.7 | 254.7 | 130.6 | ||||||||||||
balance-sheet.row.inventory | -816.51 | 0 | -415.9 | -308.2 | ||||||||||||
balance-sheet.row.other-current-assets | 1020.3 | 30.3 | 451.1 | 435.3 | ||||||||||||
balance-sheet.row.total-current-assets | 2375.14 | 683.7 | 478.1 | 524 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 431.5 | 90.2 | 136.9 | 131.6 | ||||||||||||
balance-sheet.row.goodwill | 4469.59 | 1116.5 | 722.8 | 426.3 | ||||||||||||
balance-sheet.row.intangible-assets | 3157.46 | 752 | 442.8 | 279.8 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 7627.04 | 1868.6 | 1165.6 | 706.1 | ||||||||||||
balance-sheet.row.long-term-investments | 18.13 | 4.9 | 4.5 | 5.5 | ||||||||||||
balance-sheet.row.tax-assets | 25.53 | 12.1 | 0 | 39.4 | ||||||||||||
balance-sheet.row.other-non-current-assets | 108.87 | 20.9 | 32.3 | 13 | ||||||||||||
balance-sheet.row.total-non-current-assets | 8211.07 | 1996.6 | 1339.2 | 895.5 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.account-payables | 227.99 | 48.2 | 57.2 | 96.1 | ||||||||||||
balance-sheet.row.short-term-debt | 34.52 | 9.7 | 7.1 | 7.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 2596.52 | 635.1 | 469 | 273.4 | ||||||||||||
Deferred Revenue Non Current | 763.39 | 583.7 | 2.5 | 4.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 330.46 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 1593.18 | 610.3 | 363.4 | 330.4 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 3982.56 | 938.4 | 524.4 | 280.3 | ||||||||||||
balance-sheet.row.other-liabilities | 343.45 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 222.04 | 47.7 | 63.1 | 64.8 | ||||||||||||
balance-sheet.row.total-liab | 6207.46 | 1612.6 | 957.9 | 725.8 | ||||||||||||
balance-sheet.row.preferred-stock | 1695.41 | 178.4 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 345.76 | 1.2 | 1 | 0.9 | ||||||||||||
balance-sheet.row.retained-earnings | -2691.57 | -719.2 | -606.2 | -626.8 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.76 | -1.3 | -1.2 | -0.4 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5033.92 | 1608.6 | 1465.7 | 1319.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 10586.21 | - | - | - | ||||||||||||
Total Investments | 119.15 | 4.9 | 19 | 5.5 | ||||||||||||
balance-sheet.row.total-debt | 2626.43 | 644.8 | 476.1 | 280.5 | ||||||||||||
balance-sheet.row.net-debt | 1949.02 | 452 | 287.9 | 14.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -113.04 | -113 | -19.2 | -37.6 | |||||||||||
cash-flows.row.depreciation-and-amortization | 125.7 | 123.4 | 67.2 | 60 | |||||||||||
cash-flows.row.deferred-income-tax | -97.46 | -31.3 | 0.3 | -0.5 | |||||||||||
cash-flows.row.stock-based-compensation | 40.5 | 40.5 | 34 | 16.7 | |||||||||||
cash-flows.row.change-in-working-capital | 67.77 | 21.9 | -104.4 | -13.6 | |||||||||||
cash-flows.row.account-receivables | -164.69 | -164.7 | -103 | -5.8 | |||||||||||
cash-flows.row.inventory | 0 | -10.7 | 0 | -14.1 | |||||||||||
cash-flows.row.account-payables | -6.72 | -6.7 | 13.2 | 7.3 | |||||||||||
cash-flows.row.other-working-capital | 232.94 | 204.1 | -14.6 | -1 | |||||||||||
cash-flows.row.other-non-cash-items | 119.11 | 101.1 | 10.5 | 13.8 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 142.58 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.acquisitions-net | -388.25 | 0.9 | 5.6 | -34.8 | |||||||||||
cash-flows.row.purchases-of-investments | 387.45 | -0.9 | -5.6 | -3 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0.87 | 0.9 | 5.6 | 0.5 | |||||||||||
cash-flows.row.other-investing-activites | -387.74 | -387.7 | -226.3 | 46.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -415.54 | -415.5 | -259.1 | -15.8 | |||||||||||
cash-flows.row.debt-repayment | -464.47 | -464.2 | -219.7 | -98.8 | |||||||||||
cash-flows.row.common-stock-issued | 7.6 | 479.5 | 4.5 | 13.3 | |||||||||||
cash-flows.row.common-stock-repurchased | -15.29 | -15.3 | -18.3 | -3.9 | |||||||||||
cash-flows.row.dividends-paid | -18.79 | -18.8 | -14.9 | -1.3 | |||||||||||
cash-flows.row.other-financing-activites | 772.29 | 300.1 | 380 | 61.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 281.34 | 281.3 | 131.5 | -29.5 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | -0.7 | -0.1 | |||||||||||
cash-flows.row.net-change-in-cash | 8.3 | 8.3 | -139.8 | -6.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 847.52 | 223.5 | 215.2 | 354.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 839.23 | 215.2 | 354.9 | 361.6 | |||||||||||
cash-flows.row.operating-cash-flow | 142.58 | 142.6 | -11.6 | 38.7 | |||||||||||
cash-flows.row.capital-expenditure | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.free-cash-flow | 113.84 | 113.8 | -49.9 | 13.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1963.9 | 1963.9 | 1352 | 908 | ||||||||||||
income-statement-row.row.cost-of-revenue | 1503.43 | 1503.4 | 1035.4 | 657.6 | ||||||||||||
income-statement-row.row.gross-profit | 460.47 | 460.5 | 316.6 | 250.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 26.7 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 360.23 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.operating-expenses | 481.52 | 481.5 | 336.5 | 279.5 | ||||||||||||
income-statement-row.row.cost-and-expenses | 1984.95 | 1985 | 1371.9 | 937.1 | ||||||||||||
income-statement-row.row.interest-income | 5.26 | 5.3 | 1.4 | 0.4 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.total-operating-expenses | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 58.49 | 123.4 | 67.2 | 60 | ||||||||||||
income-statement-row.row.ebitda-caps | 46.38 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -62.64 | -71.2 | -59.8 | 30.2 | ||||||||||||
income-statement-row.row.income-before-tax | -202.41 | -202.4 | -62.1 | -29.8 | ||||||||||||
income-statement-row.row.income-tax-expense | -89.36 | -89.4 | -43.4 | 0.5 | ||||||||||||
income-statement-row.row.net-income | -113.04 | -113 | -18.7 | -30.3 |
Vaak gestelde vragen
Wat is Evolent Health, Inc. (EVH) totale activa?
Evolent Health, Inc. (EVH) totale activa is 2680308000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 1067070000.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.234.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.058.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.032.
Wat is Evolent Health, Inc. (EVH) nettowinst (netto-inkomen)?
De nettowinst is -113040000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 644796000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 481525000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 192825000.000.